2-Fluoro-5-Formylbenzonitrile CAS 218301-22-5 Purity ≥98.0% Olaparib Intermediate Factory

Lus piav qhia luv luv:

Lub npe tshuaj: 2-Fluoro-5-Formylbenzonitrile

Synonyms: 3-Cyano-4-Fluorobenzaldehyde

CAS: 218301-22-5 Nr

Purity: ≥98.0%

Cov tsos mob: Yellow rau Off-White Khoom

Intermediate of Olaparib (CAS: 763113-22-0) PARP-Inhibitor

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chemical Properties:

Tshuaj npe 2-Fluoro-5-Formylbenzonitrile
Synonyms 3-Cyano-4-Fluorobenzaldehyde
CAS Nr 218301-22-5
CAT Number Qauv: RF-PI451
Tshuag xwm txheej Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula C8H4FNO
Molecular Luj 149.12 Nws
Melting Point 80.0 ~ 84.0 ℃ (lit.)
Solubility Soluble hauv Methanol
Hom Ruifu Tshuaj

Specifications:

Yam khoom Specifications
Qhov tshwm sim Yellow to Off-white Powder
Purity ≥98.0%
Moisture (KF) ≤0.50%
Tag nrho cov impurities ≤ 2.0%
Test Standard Enterprise Standard
Kev siv Intermediate of Olaparib (CAS: 763113-22-0) PARP-Inhibitor

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, Cardboard Nruas, 25kg / Nruas, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo.

Qhov zoo:

1

FAQ:

Daim ntawv thov:

2-Fluoro-5-Formylbenzonitrile (CAS: 218301-22-5) yog siv rau hauv kev npaj ntawm heterocyclic compounds li PARP inhibitors rau kev kho mob.2-Fluoro-5-Formylbenzonitrile yog siv los ua ib qho nruab nrab ntawm Olaparib (CAS: 763113-22-0).Olaparib yog ib qho me me molecule inhibitor ntawm PARP1 / PARP2 (IC50: 5/1 nM) tab sis tsis zoo tiv thaiv PARP tankyrase-1 (IC50: 1.5 µM).Olaparib (AZD-2281, lub npe lag luam Lynparza) yog FDA pom zoo rau kev kho mob qog noj ntshav, tsim los ntawm KuDOS Pharmaceuticals thiab tom qab ntawd los ntawm AstraZeneca.Nws yog PARP inhibitor, inhibiting poly ADP ribose polymerase (PARP), ib qho enzyme koom nrog hauv DNA kho.Thaum Lub Kaum Ob Hlis 2014, olaparib tau pom zoo siv los ua ib tus neeg sawv cev los ntawm EMA thiab FDA.FDA pom zoo yog nyob rau hauv germline BRCA mutated (gBRCAm) mob cancer ntawm zes qe menyuam uas tau txais peb lossis ntau dua kab ua ntej ntawm kev kho mob.

Sau koj cov lus ntawm no thiab xa tuaj rau peb